Nyxoah (NYXH) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.402x

Based on the latest financial reports, Nyxoah (NYXH) has a cash flow conversion efficiency ratio of -0.402x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-20.48 Million ≈ $-23.95 Million USD) by net assets (€50.95 Million ≈ $59.57 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Nyxoah liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Nyxoah - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Nyxoah's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Nyxoah Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nyxoah ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Kawan Food Bhd
KLSE:7216
0.001x
Jinhui Shipping and Transportation Limited
OL:JIN
0.038x
Sunflex Tech Co Ltd
TWO:3390
-0.009x
FALCON METALS LTD
F:E47
N/A
Vow ASA
OL:VOW
0.300x
International Media Acquisition Corp
NASDAQ:IMAQ
0.023x
Welspun Investments and Commercials Limited
NSE:WELINV
-0.002x
Interpark Co. Ltd
KQ:035080
0.004x

Annual Cash Flow Conversion Efficiency for Nyxoah (2017–2024)

The table below shows the annual cash flow conversion efficiency of Nyxoah from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Nyxoah.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €113.25 Million
≈ $132.41 Million
€-49.23 Million
≈ $-57.55 Million
-0.435x +4.85%
2023-12-31 €98.02 Million
≈ $114.60 Million
€-44.78 Million
≈ $-52.35 Million
-0.457x -91.15%
2022-12-31 €120.32 Million
≈ $140.67 Million
€-28.76 Million
≈ $-33.62 Million
-0.239x -40.19%
2021-12-31 €148.62 Million
≈ $173.75 Million
€-25.34 Million
≈ $-29.62 Million
-0.170x -141.38%
2020-12-31 €97.19 Million
≈ $113.63 Million
€-6.86 Million
≈ $-8.02 Million
-0.071x +95.58%
2019-12-31 €3.71 Million
≈ $4.34 Million
€-5.93 Million
≈ $-6.94 Million
-1.598x -105.20%
2018-12-31 €10.45 Million
≈ $12.22 Million
€-8.14 Million
≈ $-9.52 Million
-0.779x +57.47%
2017-12-31 €4.53 Million
≈ $5.29 Million
€-8.29 Million
≈ $-9.69 Million
-1.831x --

About Nyxoah

BR:NYXH Belgium Medical Instruments & Supplies
Market Cap
$70.32 Million
€60.15 Million EUR
Market Cap Rank
#20680 Global
#90 in Belgium
Share Price
€1.40
Change (1 day)
-0.14%
52-Week Range
€1.34 - €7.28
All Time High
€29.90
About

Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgi… Read more